SCHEMBL3874783

SCHEMBL3874783

Oc1ccc2c(c1)sc1cc(O)ccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 4/20 0.44
MAPT P10636 3/20 0.44
ALDH1A1 P00352 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
KDM4E B2RXH2 1/20 0.44
LMNA P02545 1/20 0.44
ALOX15 P16050 1/20 0.44
HSD17B10 Q99714 1/20 0.44
ESR1 P03372 11/20 0.43
ESR2 Q92731 5/20 0.43
GAA P10253 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HPGD P15428 2/20 0.41
RAB9A P51151 1/20 0.41
CA2 P00918 2/20 0.39
GPR3 P46089 1/20 0.39
ALPI P09923 1/20 0.39
ALPG P10696 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29980342 1.00 HTT (0.44) HTTMAPTALDH1A1SMN1; SMN2KDM4E
SCHEMBL3873941 0.89 GPR3 (0.61) HTTMAPTALDH1A1SMN1; SMN2KDM4E
SCHEMBL31004968 0.89 GPR3 (0.61) HTTMAPTALDH1A1SMN1; SMN2KDM4E
SCHEMBL18252670 0.87 ESR1 (0.42) HTTMAPTALDH1A1SMN1; SMN2KDM4E
SCHEMBL3876723 0.87 ALDH1A1 (0.62) HTTMAPTALDH1A1SMN1; SMN2ALOX15
SCHEMBL4915968 0.87 ALOX15 (0.42) HTTMAPTALDH1A1SMN1; SMN2KDM4E
SCHEMBL4921472 0.87 ESR1 (0.36) HTTMAPTALDH1A1SMN1; SMN2KDM4E
SCHEMBL4922476 0.87 BCKDK (0.49) MAPTALDH1A1KDM4EHSD17B10ESR1
SCHEMBL15003270 0.85 MAOA (0.49) HTTMAPTALDH1A1KDM4ELMNA
SCHEMBL24962715 0.82 ESR1 (0.47) MAPTALDH1A1SMN1; SMN2ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112779023-B Liquid crystal compound for high-frequency device DIC株式会社 2024-03-01 CN claimed
WO-2023164642-A2 CHIRAL BAND EDGE EMISSION ENHANCED ORGANIC LIGHT EMITTING DIODE-BASED DEVICES THAT EMIT MULTIPLE LIGHT WAVELENGTHS RED BANK TECHNOLOGIES LLC (US) 2023-08-31 WO claimed
US-7331997-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2008-02-19 US claimed
US-20050217038-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-10-06 US claimed
WO-2023164642-A2 CHIRAL BAND EDGE EMISSION ENHANCED ORGANIC LIGHT EMITTING DIODE-BASED DEVICES THAT EMIT MULTIPLE LIGHT WAVELENGTHS RED BANK TECHNOLOGIES LLC (US) 2023-08-31 WO disclosed
WO-2023134598-A1 POLYMERISABLE COMPOUND, COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE 烟台显华科技集团股份有限公司 2023-07-20 WO disclosed
CN-115160291-A Dibenzothiophene-based polymerizable compound and preparation method and application thereof 江苏创拓新材料有限公司 2022-10-11 CN disclosed
US-7491245-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2009-02-17 US disclosed
US-20080098535-A1 Keratin Dyeing Compounds, Keratin Dyeing Compositions Containing Them, And Use Thereof GLENN ROBERT W JR 2008-05-01 US disclosed
US-7331997-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2008-02-19 US disclosed
EP-1735059-A2 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF The Procter and Gamble Company (US) 2006-12-27 EP disclosed
WO-2005099656-A2 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF THE PROCTER & GAMBLE COMPANY (US) 2005-10-27 WO disclosed
US-20050217038-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-10-06 US disclosed
CN-1423637-A Novel substituted tricyclic compounds ASAHI CHEMICAL IND (JP) 2003-06-11 CN disclosed
US-20030040538-A1 Novel substituted tricyclic compounds ASAHI-KASEI KABUSHIKI KAISHA (JP) 2003-02-27 US disclosed
US-20030018061-A1 Novel remedies with the use of beta 3 agonist ASAHI KASEI KABUSHIKI KAISHA (JP) 2003-01-23 US disclosed
EP-1258253-A1 NOVEL REMEDIES WITH THE USE OF BETA3 AGONIST Asahi Kasei Kabushiki Kaisha (JP) 2002-11-20 EP disclosed
EP-1238973-A1 NOVEL SUBSTITUTED TRICYCLIC COMPOUNDS Asahi Kasei Kabushiki Kaisha (JP) 2002-09-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050217038-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof KRT18, CKMT1A; CKMT1B, TUBB6 HTT 3227/4885MAPT 420/4885ALDH1A1 660/4885
US-20030040538-A1 Novel substituted tricyclic compounds CPT1A, CBR1, NR1H3 HTT 2919/4885MAPT 4835/4885ALDH1A1 1241/4885
US-20080098535-A1 Keratin Dyeing Compounds, Keratin Dyeing Compositions Containing Them, And Use Thereof KRT18, CKMT1A; CKMT1B, TUBB6 HTT 3227/4885MAPT 420/4885ALDH1A1 660/4885
US-20030018061-A1 Novel remedies with the use of beta 3 agonist ADRB3, GBA3, HMGCR HTT 1636/4885MAPT 1974/4885ALDH1A1 458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.